i
Updated information on availability and use of treatments for outpatients with mild to moderate COVID-19 who are at increased risk for severe outcomes of COVID-19
-
April 25, 2022
-
Series: HAN ; 463
Details:
-
Corporate Authors:
-
Description:Distributed via the CDC Health Alert Network
Monday, April 25, 2022, 1:00 PM ET
CDCHAN-00463
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to update healthcare providers, public health departments, and the public about the availability and use of recommended therapies for COVID-19 and to advise against using unproven treatments that have known or potential harms for outpatients with mild to moderate COVID-19. For patients with mild to moderate COVID-19 who are not hospitalized and who are at increased risk for severe COVID-19 outcomes, several treatment options external icon are now widely available and accessible.
Systemic corticosteroids are not recommended external icon to treat patients with mild to moderate COVID-19 who do not require supplemental oxygen; patients who are receiving dexamethasone or another corticosteroid for other indications should continue therapy for their underlying conditions as directed by their healthcare providers. Antibacterial therapy is not recommended external icon for the treatment of COVID-19 in the absence of another indication.
Staying up to date with COVID-19 vaccination is still the best way to prevent serious outcomes of COVID-19, including severe disease, hospitalization, and death.
-
Subjects:
-
Series:
-
Document Type:
-
Place as Subject:
-
Issue:436
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: